Caterpillar Inc (CAT) 70.38 $CAT This Time, China Means

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Caterpillar Inc (CAT) 70.38 $CAT

This Time, China Means Business (Doesn't It?)
at The Street - Wed Oct 07, 12:42PM CDT
There's a lot riding on its economy, more so than ours.
JOY: 17.07 (+0.89), GE: 27.77 (+0.48), NKE: 122.10 (-1.09), UTX: 93.51 (+0.96), FCX: 13.01 (+1.18), WYNN: 71.99 (+4.14), BA: 137.02 (+2.39), MS: 32.93 (+0.57), SBUX: 58.78 (+0.09), PBR: 5.37 (+0.21), IBM: 150.09 (+1.31), BHP: 35.67 (+1.42), NAT: 16.45 (+0.15), CAT: 70.38 (-0.44), RIO: 38.19 (+2.77), AAPL: 110.78 (-0.53), YUM: 67.71 (-15.71)

Recession-Proofing Your Portfolio
at The Street - Wed Oct 07, 8:41AM CDT
The outlook on the U.S. economy is unclear, with recent data demonstrating too many contradictions: job growth remains weak, though consumer spending is strong.
GE: 27.77 (+0.48), DLTR: 62.90 (-2.29), GILD: 100.27 (+2.73), PFE: 33.29 (+0.50), MCD: 101.77 (-0.13), XOM: 79.20 (+1.31), DG: 67.45 (-1.27), CAT: 70.38 (-0.44), KORS: 42.72 (-0.65), MO: 55.90 (+0.49), PG: 73.72 (+0.32), INTC: 32.31 (+0.57)

Why Caterpillar Inc.'s Shares Plunged 15% in September
Travis Hoium, The Motley Fool - Motley Fool - Tue Oct 06, 2:25PM CDT
What: Shares of industrial equipment maker Caterpillar (NYSE: CAT) saw its stock drop 15% in September as investors started to realize that commodity markets could be in trouble for some time. So what: Commodities like gold, silver, copper,...
CAT: 70.38 (-0.44)

Caterpillar (CAT) Breaks Through Resistance at $70.27
Comtex SmarTrend(R) - Tue Oct 06, 12:31PM CDT
Shares of Caterpillar (NYSE:CAT) opened today above their pivot of $68.39 and have already reached the first level of resistance at $70.27. Analysts will be watching for a cross of the next upside pivot targets of $71.36 and $74.32.
CAT: 70.38 (-0.44)

Caterpillar Has Returned 17.2% Since SmarTrend Recommendation (CAT)
Comtex SmarTrend(R) - Tue Oct 06, 9:23AM CDT
SmarTrend identified a Downtrend for Caterpillar (NYSE:CAT) on July 1st, 2015 at $84.50. In approximately 3 months, Caterpillar has returned 17.19% as of today's recent price of $69.97.
CAT: 70.38 (-0.44)

Something Wicked This Way Comes for Market
at The Street - Tue Oct 06, 8:30AM CDT
There are worrisome signs to this short-term buying spree.
IBM: 150.09 (+1.31), NDLS: 13.86 (+0.05), MCD: 101.77 (-0.13), DD: 55.38 (+0.17), PNR: 55.19 (+0.83), CAT: 70.38 (-0.44), TWTR: 29.83 (+2.21), YUM: 67.71 (-15.71)

Famous Activist Nelson Peltz Makes GE His Largest Position -- Should You?
at The Street - Tue Oct 06, 7:07AM CDT
GE has disappointed investors for more than a decade, but something big is finally changing. The stock is 60% below where a big investor thinks it could be by 2018.
GE: 27.77 (+0.48), CAT: 70.38 (-0.44)

Here's What Is Underpinning These Market Reversals
at The Street - Tue Oct 06, 4:16AM CDT
The hope is that stocks will bounce when companies report earnings.
JOY: 17.07 (+0.89), MU: 18.62 (+0.40), AA: 10.94 (-0.04), GE: 27.77 (+0.48), DE: 78.89 (+0.45), DD: 55.38 (+0.17), CAT: 70.38 (-0.44)

SmarTrend Watching for Potential Pullback in Shares of Caterpillar After 5.30% Gain
Comtex SmarTrend(R) - Mon Oct 05, 4:14PM CDT
Caterpillar (NYSE:CAT) traded in a range yesterday that spanned from a low of $66.51 to a high of $69.48. Yesterday, the shares gained 5.3%, which took the trading range above the 3-day high of $66.10 on volume of 10.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CAT: 70.38 (-0.44)

Get Ready to Run With the Industrials
at The Street - Mon Oct 05, 2:29PM CDT
Take note of the pent-up demand for these stocks.
MMM: 147.54 (+1.75), GE: 27.77 (+0.48), NSC: 81.20 (+1.77), HON: 99.49 (+1.28), EMR: 46.35 (+0.15), NAT: 16.45 (+0.15), CAT: 70.38 (-0.44), UNP: 95.11 (+1.72)

It's Time That We All Reconsider Things
at The Street - Mon Oct 05, 11:54AM CDT
Should we really remain bearish amid a flood of positive news?
CXO: 111.04 (+3.48), PBR: 5.37 (+0.21), GE: 27.77 (+0.48), AA: 10.94 (-0.04), CMI: 112.53 (+0.36), GM: 33.05 (+0.83), WYNN: 71.99 (+4.14), LVS: 45.82 (+0.94), CAT: 70.38 (-0.44)

Why Greenbrier Companies Decoupled in September
Sean Williams, The Motley Fool - Motley Fool - Mon Oct 05, 10:05AM CDT
GBX data by YCharts . Shares of Greenbrier Companies , a manufacturer of freight cars and freight car equipment in North America and Europe, as well as barges, decoupled from the bull market in September and moved lower on the month by a...
GBX: 34.93 (-0.44), WFC: 52.19 (+0.16), CAT: 70.38 (-0.44)

Which Year's Bear Is This?; Blame Commodities: Jim Cramer's Best Blogs
at The Street - Fri Oct 02, 8:00PM CDT
Catch up on Jim Cramer's ideas from this past week as he discusses why this market is a rerun of 2011, and the ugly supply and demand imbalance in commodities.
JOY: 17.07 (+0.89), CAG: 40.94 (-0.97), NKE: 122.10 (-1.09), FB: 92.40 (-0.40), FCX: 13.01 (+1.18), LLY: 83.99 (-0.18), ANR: 0.24 (unch), PZE: 5.57 (+0.07), NFLX: 108.10 (-0.23), PBR: 5.37 (+0.21), AA: 10.94 (-0.04), CHK: 9.15 (+0.17), BHP: 35.67 (+1.42), VALE: 5.16 (+0.37), MCD: 101.77 (-0.13), GOOGL: 670.00 (-1.64), CAT: 70.38 (-0.44), RIO: 38.19 (+2.77), TWTR: 29.83 (+2.21), AAPL: 110.78 (-0.53), GIS: 55.72 (+0.02)

5 Things CalAmp Corp. Management Wants You to Know
Steve Symington, The Motley Fool - Motley Fool - Fri Oct 02, 7:47PM CDT
When CalAmp Corp. announced its fiscal second-quarter 2016 results earlier this week, investors were rightly excited. Quarterly revenue rose 18% year over over year, to $69.8 million, compared to expectations for $67.8 million, while earnings beat...
CAMP: 19.79 (+0.46), CAT: 70.38 (-0.44)

Dow 30 Stock Roundup: NIKE Beats Estimates, Pfizer Ups 2015 Outlook, Microsoft Changes Reporting Structure
Swarup Gupta - Zacks Investment Research - Fri Oct 02, 5:09PM CDT
The Dow experienced a mixed week as gains were again limited by concerns from China and a slump in biotech stocks.
KO: 41.52 (+0.56), LMT: 212.95 (+2.55), GE: 27.77 (+0.48), NKE: 122.10 (-1.09), PFE: 33.29 (+0.50), XOM: 79.20 (+1.31), WFC: 52.19 (+0.16), BA: 137.02 (+2.39), ADP: 83.65 (+1.21), CAT: 70.38 (-0.44), BRK.B: 132.68 (+1.49), MSFT: 46.80 (+0.05)

Joy Global to Cut Jobs at Franklin Facility on Weak Demand
Zacks Equity Research - Zacks Investment Research - Fri Oct 02, 3:25PM CDT
Joy Global (JOY) took the tough call to cut 85 jobs at its facility in Franklin, PA to cope with weak mining equipment demand.
JOY: 17.07 (+0.89), TEX: 19.57 (unch), CAT: 70.38 (-0.44), MTW: 16.98 (+0.21)

Weak Jobs, Wages Data Are Red Flag To Fed, Investors
at Investor's Business Daily - Fri Oct 02, 12:42PM CDT
The U.S. economy added just 142,000 jobs last month, the Labor Department said Friday. That was far less than the 203,000 expected. Along with a big August downward revision and weak wage data, the news sent U.S. stocks tumbling and raised questions...
GE: 27.77 (+0.48), CAT: 70.38 (-0.44), BA: 137.02 (+2.39)

Caterpillar's Job Cuts Show U.S. Will Feel Emerging-Market Pain
at The Street - Fri Oct 02, 11:31AM CDT
Caterpillar's job cuts mark just the beginning of an emerging-market sales downturn for U.S. exporters of construction equipment, machinery and engines.
JOY: 17.07 (+0.89), CMI: 112.53 (+0.36), CAT: 70.38 (-0.44)

The Dow's 3 Worst Stocks This Summer
Dan Caplinger, The Motley Fool - Motley Fool - Fri Oct 02, 9:52AM CDT
Image: Wikimedia Commons, courtesy Jean-Pierre Lavoie. The stock market had a tough summer, with the Dow Jones Industrials suffering losses of more than 1,300 points and ending the quarter still in correction territory more than 10% below its...
UTX: 93.51 (+0.96), DD: 55.38 (+0.17), CAT: 70.38 (-0.44)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 352

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 37

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Stock Market News: Nasdaq Dips as Applied Materials Shines

Updated Category News Views 191

Stock Market Declines on Nasdaq Today, U.S. stocks faced challenges with the Nasdaq Composite dropping significantly. The market opened lower with declines across major indices, signaling a cautious trading atmosphere. Market Overview As the day progressed, the Dow Jones Industrial Average fell by 1.21% to 46,882.86, while the NASDAQ retreated by 1.51%, settling at...

Continue Reading
Fastly Eyewitness: A Look at Recent Stock Performance

Updated Category News Views 205

Fastly's Impressive Stock Surge Fastly stock has recently shown remarkable movement, trading at near recent highs, indicating strong investor confidence in the company. The notable increase has left many wondering how long this momentum can be sustained. AI Transformation Sparks Interest Shifting Perspectives in Technology The recent ascent of Fastly's stock is largely...

Continue Reading
Exploring the Transformation of Social Media Management Market

Updated Category News Views 139

Understanding the Evolution of the Social Media Management Market The social media management market is experiencing remarkable growth. From a value of $17.5 billion in 2022, projections indicate it may reach $51.8 billion by 2027. This surge represents a compound annual growth rate (CAGR) of 24.2%. Companies worldwide are adapting to the increasing reliance on social...

Continue Reading
WestBond Enterprises Posts Year-End Financial Results and Outlook

Updated Category News Views 166

WestBond Enterprises Financial Overview WestBond Enterprises Corporation (TSX-V: WBE), a notable player in the manufacturing sector, has reported a financial loss of $52,380 for the year ending in March, reflecting a notable decrease from the previous year's loss of $210,683. Despite the loss, the company experienced a 4.9% increase in sales, which totaled $9,673,002,...

Continue Reading
Investors of Ultra Clean Urged to Act Amidst Stock Decline

Updated Category News Views 239

Investigation by Faruqi & Faruqi for Ultra Clean Investors Faruqi & Faruqi, LLP, a prominent national securities law firm, is reaching out to investors who have experienced losses exceeding $50,000 in Ultra Clean Holdings, Inc. (NASDAQ: UCTT). The firm aims to discuss potential legal options available to these investors following troubling financial disclosures from Ultra...

Continue Reading